Biohemijski i hematološki nalazi i faktori rizika povezani sa oštećenjem bubrega kod pacijenata sa COVID-19

  • Yosra Yaghmour Department of Medical Laboratory Sciences, Al-Ahliyya Amman University, Zip code (19328), Amman, Jordan. Pharmacological and diagnostic research center, Al-Ahliyya Amman University, Zip code (19328), Amman, Jordan.
  • Ala'a Shraim Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan. https://orcid.org/0000-0001-7021-8847
  • Manal Abbas Department of Medical Laboratory Sciences, Al-Ahliyya Amman University, Zip code (19328), Amman, Jordan. Pharmacological and diagnostic research center, Al-Ahliyya Amman University, Zip code (19328), Amman, Jordan. https://orcid.org/0000-0002-8962-1879
DOI: https://doi.org/10.5937/jomb0-37343

Sažetak


Background : COVID-19 is a new pandemic that has infected millions of people worldwide and caused a high rate of morbidity and mortality. COVID-19 may have a harmful effect on body organs especially, the kidneys.

Aims: The main aim of our research is to study the association between the severity of COVID-19 disease and biochemical parameters related to kidney function and to investigate certain risk factors of COVID-19-associated kidney disease.

Methods: A total of 174 individuals, 121 COVID-19 positive and 53 COVID-19 negative were enrolled in this study. The relation between COVID-19 infection, severity, kidney function test, hematological indicators were examined.

Results: The most prominent symptoms among COVID-19 were fever (95%) and fatigue (92%). Regarding biochemical parameters, median creatinine, MPV, and CRP were found to be significantly higher in COVID-19 patients, whereas median eGFR, Na⁺, WBC, MCH, MCHC, and eosinophil percentage were significantly lower in this group. Severely infected patients were observed to have higher urea, creatinine, neutrophils, and NLR. However, median sodium, eGFR, hemoglobin, hematocrit, RBC, lymphocytes, and platelets count were significantly lower in the severe group. Urine examination of severe group showed a significantly lower specific gravity, while urine pH, protein, and glucose were significantly higher.

Conclusion : Our analysis indicates that COVID-19 infection affects kidney function mainly creatinine level, urea, eGFR, Na⁺ and urine protein. Additionally, comorbidities such as older age (≥65), hypertension, taking medications, and CRP (≥33.55mg/L) are considered risk factors which are more likely to contribute to kidney impairment in COVID-19 positive patients.

 

Biografija autora

Ala'a Shraim, Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan.

Assistant Professor in Biochemistry 

Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan.

Reference

1. Zu ZY, Jiang MD, Xu PP, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020;296(2):E15-E25.
2. Khoshdel-Rad N, Zahmatkesh E, Shpichka A, Timashev P, Vosough M. Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? J Nephrol. 2021;34(1):3-5.
3. Dreher M, Kersten A, Bickenbach J, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl Int. 2020;117(16):271-278.
4. D'Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020;26(6):832-834.
5. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, et al. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3): e2176.
6. Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on Kidney Dysfunctions of COVID-19 Patients (3/19/2020). Available at http://dx.doi.org/10.2139/ssrn.3559601.
7. Chen YT, Shao SC, Hsu CK, Wu IW, Hung MJ, Chen YC. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care. 2020;24(1):346.
8. Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747-764.
9. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193-1194.
10. Zhang YM, Zhang H. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Clin J Am Soc Nephrol. 2020;15(7):1044-1046.
11. The Hashemite Kingdom of Jordan Ministry of Health (2018) National Registry of End Stage Renal Disease Annual Report. Available at: https://kaa.moh.gov.jo/Echobusv3.0/SystemAssets/bd28e64d-6221-4b94-8bb5-1ecf8c2bd446.pdf.
12. Khalil AA, Abed MA, Ahmad M, Mansour AH. Under-diagnosed chronic kidney disease in Jordanian adults: prevalence and correlates. J Ren Care. 2018;44(1):12-18.
13. Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis. Am J Emerg Med. 2021; 41:110-119.
14. Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020;92(11):2409-2411.
15. Cheng Y, Luo R, Wang K, et al. kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838.
16. Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93(2):786-793.

17. Zhao, J. A COVID-19 patient with AKI. Journal of the American Society of Nephrology, 2020, 813-813.‏
18. Huart J, Bouquegneau A, Lutteri L, et al. Proteinuria in COVID-19: prevalence, characterization and prognostic role. J Nephrol. 2021;34(2):355-364.
19. Kanic V, Vollrath M, Kompara G, Suran D, Hojs R. Women and acute kidney injury in myocardial infarction. J Nephrol. 2018;31(5):713-719.
20. Lim JH, Jung HY, Choi JY, et al. Hypertension and Electrolyte Disorders in Patients with COVID-19. Electrolyte Blood Press. 2020;18(2):23-30.
21. Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262-265.
22. Liu R, Ma Q, Han H, et al. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019. Clin Chem Lab Med. 2020;58(7):1121-1124.
23. Bergamaschi G, Borrelli de Andreis F, Aronico N, et al. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239-246.
24. Wang C, Zhang H, Cao X, et al. Red cell distribution width (RDW): a prognostic indicator of severe COVID-19. Ann Transl Med. 2020;8(19):1230.
25. Naoum FA, Ruiz ALZ, Martin FHO, Brito THG, Hassem V, Oliveira MGL. Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID-19. Int J Lab Hematol. 2021;43 Suppl 1:124-128.
26. Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-1208.
27. Aydınyılmaz F, Aksakal E, Pamukcu HE, et al. Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use. Clin Appl Thromb Hemost. 2021; 27:10760296211048808.
28. Smadja DM, Guerin CL, Chocron R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020;23(4):611-620.
29. See YP, Young BE, Ang LW, et al. Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study. Nephron. 2021;145(3):256-264.
30. Chang TJ, Zheng CM, Wu MY, et al. Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population [published correction appears in Sci Rep. 2020 Feb 13;10(1):2822]. Sci Rep. 2018;8(1):6908.
31. Samrah SM, Al-Mistarehi AW, Ibnian AM, et al. COVID-19 outbreak in Jordan: Epidemiological features, clinical characteristics, and laboratory findings. Ann Med Surg (Lond). 2020; 57:103-108.

32. Naidoo S, Meyers AM. Drugs and the kidney. S Afr Med J. 2015;105(4):2683. doi:10.7196/samj.9537.
33. Procaccini FL, Alcázar Arroyo R, Albalate Ramón M, et al. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study. Clin Kidney J. 2021;14(6):1557-1569.
34. Rastad H, Karim H, Ejtahed HS, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020; 12:57.
Objavljeno
2022/07/21
Broj časopisa
Vol. 42 Br. 1 (2023): Journal of Medical Biochemistry
Rubrika
Original paper

Sva prava zadržana (c) 2022 Yosra Yaghmour, Ala'a Shraim, Manal Abbas

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.